[Nested PCR detection of WT1 expression in the peripheral blood in childhood acute leukemia]
Detection of minimal residual disease (MRD) in childhood leukemia is not possible by cytomorphology or Southern blotting due to their low sensitivity. On the other hand, the use of DNA markers and PCR amplification is helpful in a smaller proportion of leukemia cases (20-30%). Since childhood leukemia is characterized by WT1 gene expression in the majority of cases,monitoring of WT1 expression in the peripheral blood was suggested to be a method of choice to detect MRD. We have studied 22 newly diagnosed childhood acute leukemias and 17 cases in remission. As controls, 19 patients with non-leukemic diseases were included. The majority of our acute leukemia cases (80%) were proved to be WT1 expressors using a highly sensitive nested PCR technique. Ten WT1 + cases have been monitored for a year throughout the inicial therapy phase, using peripheral blood tests. We observed that in 20% of the follow-up cases MRD was suggested which was not detectable by any other methods. It is our intention to introduce this new molecular technique into the clinical management of childhood acute leukemia.
Rásó
Erzsébet
E
Tumor Progressziós Osztály, Országos Onkológiai Intézet, Budapest, H1122, Hungary. raso@oncol.hu
Varga
Norbert
N
Tímár
József
J
Magyarosy
Edina
E
Minimális reziduális betegség monitorozása gyermekkori akut leukémiában a WT1 gén perifériás vérben történô expressziójának nyomonkövetésével.